Amarin (AMRN) CEO Lynch To Step Down, Remains Chairman
Down)
Amarin Corporation plc (NASDAQ: AMRN) said after the closing of the $70 million private placement announced today, Mr. Thomas Lynch, Chairman and Chief Executive Officer of Amarin, has decided he will step down as CEO and will continue as Chairman.
Dr. Declan Doogan, Amarin's Head of Research and Development, has agreed to assume the role of Interim CEO.
Dr. Declan Doogan, Amarin's Head of Research and Development, has agreed to assume the role of Interim CEO.
You May Also Be Interested In
- Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions
- Becton Dickinson (BDX) CEO Forlenza Assumes Role of Chairman
- Splunk (SPLK) Says Scott Thompson Resigns from Board
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
